Search Results 281-290 of 6022 for albumin

  1. Non-Hodgkin Lymphoma Clinical Trials - Mayo Clinic Research

    Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

  2. IS-002 in Prostate Cancer - Mayo Clinic

    Albumin: < LLN;; Hepatic function at screening: AST and/or ALT: > 2.5 x ULN;; Total Bilirubin (serum): >1.5 x ULN. 4. Subject has received neo-adjuvant ...

  3. A Study to Evaluate Collecting of Health Related Quality of Life Data in Newly Diagnosed AL Amyloidosis Patients - Mayo Clinic

    The purpose of this study is to evaluate the usefulness of collecting health related quality of life data on newly diagnosed AL amyloidosis patients.

  4. Phase 3 Study of T-DXd and Rilvegostomig versus SoC in Advanced HER2-expressing Biliary Tract Cancer - Mayo Clinic

    Serum albumin ≥ 2.5 g/dL • Creatinine clearance ≥ 50 mL/min (as calculated using the Cockcroft and Gault equation); International normalized ratio ...

  5. A Study to Evaluate RVT-1401 for the Treatment of Patients with Active, Moderate-to-severe Graves' Ophthalmopathy - Mayo Clinic

    Albumin level < 3.5 g/dL at Screening. Known advanced liver disease including any diagnosis of cirrhosis of any stage. Non- alcoholic fatty liver disease ...

  6. A Study to Define Axl Expression Level in Skin Biopsy Specimens from Patients with Skin Cancer in Relation to Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to define the presence and role of Axl in the risk of skin cancers in patients with CLL as well as non-CLL patients. Participation ...

  7. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

    Serum albumin > 2 g/dL; Shortening fraction of >= 27% by echocardiogram; Ejection fraction of >= 50% by radionuclide angiogram; All patients and/or their ...

  8. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

    - Serum albumin ≥2.8 g/dL - Aspartate aminotransferase and alanine aminotransferase (ALT) ≤ 3.0 × ULN (or ≤ 5.0 × ULN, if liver metastases are present) ...

  9. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Albumin > 2.5 mg/dL (25 g/L); International normalized ratio (INR) or prothrombin time (PT) =< 1.5 x ULN unless subject is receiving anticoagulant therapy as ...

  10. Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) - Mayo Clinic

    Serum albumin < 2.5 mg/dL. Evidence of another uncontrolled condition which, in the judgment of the investigator, could interfere with participation in the ...